#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrointestinal stromal tumour Biotinidase deficiency Dementia Alzheimer's type Penile cancer Dermatitis Diffuse large B-cell lymphoma recurrent Prostate cancer Congenital growth hormone deficiency Nasopharyngeal cancer Fallopian tube cancer Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Meningitis meningococcal High-grade B-cell lymphoma Chorioretinitis B-cell small lymphocytic lymphoma recurrent More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV Osteosarcoma metastatic Waldenstrom’s macroglobulinaemia recurrent – Treatment Hyperoxaluria – Life with Disease Cystic fibrosis – Trials in Disease Mantle cell lymphoma stage III – Basic Information Langerhans’ cell histiocytosis – Diagnostics Mucous membrane pemphigoid – Diagnostics Hereditary optic atrophy – Diagnostics Medulloblastoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metyrapone Bp PEGVISOMANT Cipepofol Rifabutin Feladilimab Vesleteplirsen Doxazosin Mesilate Pyruvic Acid Sunitinib HLX43 Rbl016.2 Allogeneic Faecal Microbiota Retifanlimab Estradiol Valerate Absk021 Hydrochloride Hydrate A52 GLYCYL-TYROSINE VMX-C001 Colesevelam Ponatinib More therapies…

    Learn about Your Condition

    Small for dates baby Oropharyngeal cancer recurrent Thrombosis Sepsis Electrocorticogram Renal cancer recurrent Medulloblastoma recurrent Cortical dysplasia Monogenic diabetes Skin candida Neuromuscular scoliosis Dengue fever Guttate psoriasis Synovial sarcoma metastatic Skin neoplasm excision More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Baricitinib
    Austria Belgium Czechia France Germany Greece +8

  • Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

    Not recruiting

    2 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Bemcentinib
    Belgium Czechia France Greece Ireland Italy +4

  • Study on Pamapimod and Pioglitazone for COVID-19 Recovery in Non-Hospitalized Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Pamapimod
    • Pioglitazone Hydrochloride
    Germany

  • Study on Tecovirimat for Treating Monkeypox in Patients with Confirmed Infection

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tecovirimat
    Belgium France Germany Italy The Netherlands Norway +2

  • Study on Ganciclovir and Valganciclovir for Preventing Cytomegalovirus in High-Risk Heart Surgery Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Valganciclovir
    • Ganciclovir
    Spain

  • Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • Bulevirtide
    Austria Belgium France Germany The Netherlands Romania +1
Previous Page
1 … 45 46 47 48 49 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!